160 related articles for article (PubMed ID: 6987179)
1. Host defenses in murine malaria: immunological characteristics of a protracted state of immunity to Plasmodium yoelii.
Murphy JR
Infect Immun; 1980 Jan; 27(1):68-74. PubMed ID: 6987179
[TBL] [Abstract][Full Text] [Related]
2. Host defenses in murine malaria: evaluation of the mechanisms of immunity to Plasmodium yoelii infection.
Murphy JR; Lefford MJ
Infect Immun; 1979 Feb; 23(2):384-91. PubMed ID: 422246
[TBL] [Abstract][Full Text] [Related]
3. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection.
McColm AA; Dalton L
Ann Trop Med Parasitol; 1983 Aug; 77(4):355-77. PubMed ID: 6357121
[TBL] [Abstract][Full Text] [Related]
4. Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium.
Hargreaves J; Yoeli M; Nussenzweig RS
Ann Trop Med Parasitol; 1975 Sep; 69(3):289-99. PubMed ID: 1098589
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.
Jarra W; Brown KN
Parasite Immunol; 1989 Jan; 11(1):1-13. PubMed ID: 2648258
[TBL] [Abstract][Full Text] [Related]
6. Host defenses in murine malaria: induction of a protracted state of immunity with a formalin-killed Plasmodium berghei blood parasite vaccine.
Murphy JR; Lefford MJ
Infect Immun; 1978 Dec; 22(3):798-803. PubMed ID: 365770
[TBL] [Abstract][Full Text] [Related]
7. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation.
Murphy JR
Infect Immun; 1981 Jul; 33(1):199-211. PubMed ID: 7021424
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
9. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
[TBL] [Abstract][Full Text] [Related]
10. Host defenses in murine malaria: analysis of the mechanisms of immunity to Plasmodium berghei generated in response to immunization with formalin-killed blood-stage parasites.
Murphy JR
Infect Immun; 1979 Jun; 24(3):707-12. PubMed ID: 381198
[TBL] [Abstract][Full Text] [Related]
11. Host defenses in murine malaria: humoral immunity to Plasmodium berghei in mice.
Murphy JR; Logie PS
Am J Trop Med Hyg; 1984 May; 33(3):347-56. PubMed ID: 6375406
[TBL] [Abstract][Full Text] [Related]
12. Antibody-independent immunity to reinfection malaria in B-cell-deficient mice.
Grun JL; Weidanz WP
Infect Immun; 1983 Sep; 41(3):1197-204. PubMed ID: 6350181
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
Sayles PC; Wassom DL
J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
[TBL] [Abstract][Full Text] [Related]
14. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
16. The immunological response of CBA mice to P. yoelii. II. The passive transfer of immunity with serum and cells.
Jayawardena AN; Targett GA; Leuchars E; Davies AJ
Immunology; 1978 Jan; 34(1):157-65. PubMed ID: 342396
[TBL] [Abstract][Full Text] [Related]
17. Rapid parasite multiplication rate, rather than immunosuppression, causes the death of mice infected with virulent Plasmodium yoelii.
Fahey JR; Spitalny GL
Infect Immun; 1987 Feb; 55(2):490-3. PubMed ID: 2948918
[TBL] [Abstract][Full Text] [Related]
18. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
[TBL] [Abstract][Full Text] [Related]
19. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
20. Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.
Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
Malar J; 2011 Apr; 10():103. PubMed ID: 21518429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
